Molecular Partners AG

Molecular Partners is a privately owned biopharmaceutical company, located in Zurich, Switzerland, that is pioneering the development of a novel class of targeted protein therapeutics termed DARPins. DARPins are as target specific and potent as monoclonal antibodies. Yet, being small proteins, they overcome the known limitations of conventional protein-based therapeutic approaches.

Details


Adresse:
Molecular Partners AG

Wagistrasse 14
8952 Zürich-Schlieren
Schweiz
Arbeitsgebiet:
Forschung & Entwicklung
Sonstige Tätigkeitsfelder
Expansion:
international
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2004